CLOV Biopharma Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Buyout/LBO
- Investors
-
1
CLOV Biopharma General Information
Description
Provider of laboratory and scientific research services intended to prevent the spread of respiratory viruses. The company specializes in research, development, and assessment of the potential commercial viability of cedar leaf oil and cedar leaf oil vapor, enabling pharmaceutical, healthcare, and biotechnology sectors to prevent the spread of coronavirus and similar potentially pathogenic respiratory viruses.
Contact Information
Corporate Office
- Vancouver, British Columbia
- Canada
Corporate Office
- Vancouver, British Columbia
- Canada
CLOV Biopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Buyout/LBO | 12-Feb-2020 | Completed | Startup |
CLOV Biopharma Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FutureGen Industries | Venture Capital | Majority |
CLOV Biopharma FAQs
-
When was CLOV Biopharma founded?
CLOV Biopharma was founded in 2020.
-
Where is CLOV Biopharma headquartered?
CLOV Biopharma is headquartered in Vancouver, Canada.
-
What industry is CLOV Biopharma in?
CLOV Biopharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is CLOV Biopharma a private or public company?
CLOV Biopharma is a Private company.
-
What is CLOV Biopharma’s current revenue?
The current revenue for CLOV Biopharma is .
-
Who are CLOV Biopharma’s investors?
FutureGen Industries has invested in CLOV Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process